REG - Centrica PLC - Director Declaration

CentricaAnnouncement

19/11/2025 11:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251119:nRSS1973Ia&default-theme=true

RNS Number : 1973I  Centrica PLC  19 November 2025

19 November 2025

Centrica plc

('Centrica' or 'the Company')

Director Declaration

In accordance with UK Listing Rule 6.4.9, Centrica notes that Jupiter Fund
Management plc ('Jupiter') has today announced that Nathan Bostock,
Non-Executive Director and Chair of the Audit and Risk Committee of Centrica,
has been appointed as a non-executive director and Chair designate of Jupiter
with effect from 1 March 2026 and will take on the role of Chair of Jupiter,
subject to regulatory approval, with effect from 1 April 2026.

Nathan will continue to serve on the Centrica Board and as Chair of the Audit
and Risk Committee until no later than the end of July 2026 (subject to
re-election at Centrica's 2026 Annual General Meeting). A further update on
his successor will be provided in due course. In the meantime, Nathan's
current responsibilities with Centrica remain unchanged.

There are no other matters requiring disclosure under UK Listing Rule 6.4.6 or
6.4.9.

 

Enquiries:

Investors and Analysts

E: ir@centrica.com

Media

T: 01784 843000

E: media@centrica.com

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNPKCBPKBDDPDD



            Copyright 2019 Regulatory News Service, all rights reserved